GSK

Ideaya Biosciences Selects Lead Pol Theta Helicase Inhibitor for Development With GlaxoSmithKline

Rectal Cancer Patient Subset Shows Complete Response to Immunotherapy in Small Study

Precision Cancer Consortium Launches With Bayer, GSK, Roche, Novartis as Founding Members

LifeMine Therapeutics Nets $175M in Series C, Inks GSK Deal to Advance Genomically Informed Drugs

Lyell Immunopharma's IND for T-Cell Receptor Therapy Gets FDA Clearance

23andMe Gets $50M Payment as GSK Extends Companies' Drug Discovery Alliance

Tempus, GSK Initiate Phase II Trial of Niraparib in PALB2-Mutated Tumors

In Brief This Week: Gilead, Iovance, Eli Lilly, Merck KGaA, GlaxoSmithKline, Aspira Women's Health

FDA Approves GlaxoSmithKline's Jemperli, Roche’s Ventana CDx for dMMR Solid Cancers

FDA Approves GSK's Jemperli With Ventana CDx for dMMR Endometrial Cancer

CHMP Recommends Approval of GSK's Dostarlimab in Endometrial Cancer

FDA Accepts Ideaya Biosciences' IND for MAT2A Inhibitor

Merck KGaA Discontinues Phase III Lung Cancer Trial of Bintrafusp Alfa

JP Morgan Healthcare, Day 2: Eli Lilly, Pfizer, GlaxoSmithKline, Clovis Oncology, Invitae, and More

Ideaya Biosciences Submits IND Application to Study MAT2A Inhibitor in Solid Tumors

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

Adaptive Biotechnologies, GlaxoSmithKline Collaborate on MRD Testing

GSK Gets Broad Zejula Indication in Ovarian Cancer; FDA Deems Myriad Genetics' Test Complementary